Skip to content

Rapport Therapeutics, Inc.

RAPP· NasdaqCore metricsCIK 2012593

Pharmaceutical preparations551 peers

Last sale
Nov 2, 2026 · +0.36%
Market cap
$1.49B
59.28M shares
Filings
254
$0.00
Q3 2026
—
-$40.24M
Q3 2026N/M FY25 yoy
-$44.09M
Q3 2026N/M FY25 yoy
-$96.31M
Q3 2026derivedN/M FY25 yoy
-$0.84
Q3 2026N/M FY25 yoy
$74.75M
Q3 2026−7.3% FY25 yoy
$1.49B
—
—
3.8×
-5.92%
—

FY2025 figures · derived

Price

$25.116.74%$1.82past year
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00Q3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Rapport Therapeutics, Inc. is the 115th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Rapport Therapeutics, Inc. · CIK 2012593 · Engraved from SEC EDGAR